Negative prognostic value of high levels of intracellular poly(ADP-ribose) in non-small cell lung cancer

Judith Michels; Julien Adam; Aïcha Goubar; Florine Obrist; Diane Damotte; Angélique Robin; Marco Alifano; Ilio Vitale; Ken A. Olaussen; Philippe Girard; Isabelle Cremer; Maria Castedo; Jean‐Charles Soria; Guido Guido Kroemer

doi:10.1093/annonc/mdv393

Back

Negative prognostic value of high levels of intracellular poly(ADP-ribose) in non-small cell lung cancer

Article 2015 en

Discussion(0)

No comments yet. Be the first to comment.

Related publications

Article2014

Abstract 4691: Overactivation of poly (ADP-ribose) polymerase (PARP) in localised non-small cell lung cancer (NSCLC) predicts dismal prognosis

Judith Michels, Aïcha Goubar, Julien Adam, Lorenzo Galluzzi, Ken A. Olaussen, Angélique Robin, Philippe Girard, Isabelle Kremer, Maria Castedo, Jean‐Charles Soria, Guido Guido Kroemer

Article2013

Prognostic value of LIPC in non-small cell lung carcinoma

Lorenzo Galluzzi, Aïcha Goubar, Ken A. Olaussen, Ilio Vitale, Laura Senovilla, Judith Michels, Angélique Robin, Nicolas Dorvault, Benjamin Besse, Pierre Validire, Pierre Fouret, Carmen Behrens, Ignacio I. Wistuba, Jean‐Charles Soria, Guido Guido Kroemer

Article2009

Poly(ADP-ribose) polymerase inhibitors in cancer treatment: A clinical perspective

Shahneen Sandhu, Timothy A. Yap, Johann S. de Bono

Article2011

The Emerging Role of Poly(ADP-Ribose) Polymerase Inhibitors in Cancer Treatment

Shahneen Sandhu, Timothy A. Yap, Johann S. de Bono

Article2022

Clinical Application of Poly(ADP-ribose) Polymerase (PARP) Inhibitors in Prostate Cancer

Andrisha–Jade Inderjeeth, Monique Topp, Elaine Sanij, Elena Castro, Shahneen Sandhu